How Interest Rates Are Reshaping Medical CRE Pricing

For much of the past decade, commercial real estate portfolios traded at a premium to the sum of their individual assets. Buyers were willing to pay for scale, operational efficiency, and immediate income growth. In healthcare real estate, portfolios offered a way to deploy significant capital quickly while establishing a foothold in high-quality markets.

 

That dynamic shifted in mid-2022. As interest rates rose, the economics of acquisitions changed just as quickly. Leverage pulled back, borrowing costs increased, and portfolio transactions that once commanded premiums began trading closer to, or even below, the value of their underlying assets.

 

Demand for healthcare real estate didn’t disappear, but it evolved. Transaction velocity slowed as capital became more expensive and purchasing power declined. Institutional buyers stepped back, and although private investors and 1031 exchange buyers remained active, they approached deals with greater pricing discipline.

 

Even in this environment, transactions continued to get done, just with a different focus. Buyers prioritized income durability and long-term hold characteristics over leverage. Rather than assuming portfolios deserved a premium, pricing became more grounded. Simplicity, yield, and clean cash flow took center stage. As a result, complex portfolios lost their edge, while straightforward deals gained it.

 

Now, with rates stabilizing and institutional capital beginning to return, the question has resurfaced: are portfolio premiums coming back?

Why Portfolios Once Traded at Premiums

Before 2022, several factors drove those premiums. Debt was inexpensive, with borrowing costs often sitting between 3 and 4 percent. This allowed buyers to use higher leverage while still achieving strong returns. When borrowing costs fall below cap rates, leverage amplifies returns and supports higher pricing.

 

At the same time, scale played a critical role. Institutional investors need to deploy capital efficiently, and executing a single $50 million transaction is far easier than placing that capital one property at a time. Portfolios offered immediate diversification across tenants, locations, and lease terms, while also improving operational efficiency.

 

Competition from institutional buyers further pushed pricing higher. Public healthcare REITs such as Welltower, Ventas, and Healthcare Realty Trust were aggressive acquirers with access to low-cost capital and constant pressure to grow. Their presence consistently set pricing at the top of the market.

 

These forces reinforced one another. Cheap debt increased buying power, scale created strategic value, and institutional demand drove pricing upward. In that environment, portfolios weren’t just attractive, they were often the most competitive way to transact.

Why Portfolio Discounts Emerged

When rates increased in 2022, the shift was immediate. Borrowing costs rose sharply, often doubling in a short period, while lenders reduced leverage. Loan-to-value ratios that had been in the 65 to 70 percent range dropped into the mid-50s. Together, these changes significantly reduced purchasing power.

 

At the same time, the buyer pool shrank. Highly leveraged buyers moved to the sidelines, leaving fewer participants competing for deals. Naturally, less competition led to softer pricing.

 

More importantly, portfolios began to look fundamentally different under a higher cost of capital. Factors such as lease rollover, tenant credit, and capital expenditure requirements moved from secondary considerations to primary drivers of value. Buyers no longer viewed portfolios as a single income stream, they began underwriting each asset individually. Once that happens, weaker assets drag down the entire portfolio.

 

As a result, single-asset deals became more attractive. They are easier to finance, easier to understand, and easier to control. This shift in demand further pressured portfolio pricing.

Where the Market Stands Today

Heading into 2026, the market is beginning to rebalance. Interest rates have stabilized, bringing greater predictability back to debt markets. While financing remains more expensive than before, buyers can now underwrite with more confidence.

 

Institutional capital is also becoming more active. Groups that spent the past few years focused on balance sheet discipline are now shifting back toward growth, with REITs and larger private equity platforms increasingly pursuing portfolio opportunities.

 

At the same time, supply remains constrained. Many owners locked in low-cost debt and face little pressure to sell, while new development has slowed due to higher construction costs and tighter financing. As a result, high-quality portfolios remain limited.

 

This combination, returning demand and constrained supply, creates the foundation for pricing stabilization.

Portfolio Roll-Ups Today

Portfolio aggregation is re-emerging, but with a different approach. Investors still need to deploy capital, and many funds raised in recent years remain under-allocated. Portfolios offer a solution by providing both scale and speed.

 

However, underwriting has fundamentally changed. Buyers are now taking a bottom-up approach, evaluating each asset on its own merits before considering any portfolio-level benefits. If the individual pieces don’t work, the portfolio doesn’t work.

 

As a result, portfolios with inconsistent tenant credit, near-term lease rollover, or deferred capital needs are not achieving premiums, and in some cases are still trading at discounts. Scale still matters, but only when paired with consistency and income durability.

Will Portfolio Premiums Return?

Portfolio premiums are beginning to return, but not universally. The market is becoming more selective.

 

High-quality portfolios, those with strong tenant credit, long lease terms, and locations tied to dominant healthcare systems, are starting to achieve tighter pricing relative to single-asset deals. Meanwhile, portfolios lacking these characteristics are still being priced on a sum-of-the-parts basis, or even at a discount, particularly when near-term leasing or capital risk is present.

 

The spread between strong and average portfolios has widened, often by 50 to 150 basis points depending on risk.

 

The shift is straightforward: premiums are no longer assumed, they are earned. They come from income durability, credit strength, and how seamlessly a portfolio integrates into an existing platform.

Recapture as a Value Driver

Another important evolution is how investors view recapture. In a higher cost of capital environment, returns are no longer driven solely by yield compression. Internal growth has become increasingly important.

 

In healthcare real estate, this creates opportunity. Many leases signed seven to ten years ago are below current market levels, particularly in high-growth regions such as Florida and the broader Sunbelt. As space turns over, landlords can reset rents, improve tenant mix, and drive NOI growth.

 

In some cases, rent increases can reach 10 to 25 percent, materially improving IRRs and helping offset higher exit cap assumptions. However, execution is critical. Healthcare tenancy is sticky, buildout costs are significant, and downtime can impact cash flow. Investors are underwriting these scenarios carefully, factoring in demand, referral networks, and replacement costs that can exceed $150 to $300 per square foot.

 

When executed well, recapture is not a disruption, it is a strategy.

What Investors Should Watch

Portfolio pricing will continue to follow capital markets. If rates remain stable and lending conditions normalize, institutional buyers will become more active, increasing competition and supporting pricing.

 

Early signs of this are already emerging. Transaction volume is improving, and institutional groups are re-entering the market with clearer return thresholds. At the same time, private and 1031 buyers continue to provide a steady bid for single-asset deals, helping establish a pricing floor.

 

The key relationship to watch is the spread between borrowing costs and in-place yields. When that spread tightens, portfolio premiums tend to follow. When it doesn’t, simplicity continues to win.

Final Thoughts

The market never stopped valuing portfolios, it simply lost the ability to pay for them. As capital returns and competition increases, portfolios will regain importance.

 

This time, however, scale alone won’t be enough. The portfolios that command premiums will be those defined by strong fundamentals, durable income, and clear, executable upside.